Heart rate, arterial pressure and propofol-sparing effects of guaifenesin in dogs.
co-induction
dog
guaifenesin
propofol
Journal
Veterinary anaesthesia and analgesia
ISSN: 1467-2995
Titre abrégé: Vet Anaesth Analg
Pays: United States
ID NLM: 100956422
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
07
06
2022
revised:
05
10
2022
accepted:
06
10
2022
pubmed:
8
11
2022
medline:
25
1
2023
entrez:
7
11
2022
Statut:
ppublish
Résumé
To evaluate the heart rate (HR) and systemic arterial pressure (sAP) effects, and propofol induction dose requirements in healthy dogs administered propofol with or without guaifenesin for the induction of anesthesia. Prospective blinded crossover experimental study. A total of 10 healthy adult female Beagle dogs. Dogs were premedicated with intravenous (IV) butorphanol (0.4 mg kg Propofol doses (mean ± standard deviation) for treatments saline, G50 and G100 were 3.3 ± 1.0, 2.7 ± 0.7 and 2.1 ± 0.8 mg kg When administered as a co-induction agent in dogs, guaifenesin reduced propofol requirements for tracheal intubation. HR increased and sAP and f
Identifiants
pubmed: 36344374
pii: S1467-2987(22)00195-7
doi: 10.1016/j.vaa.2022.10.001
pii:
doi:
Substances chimiques
Propofol
YI7VU623SF
Anesthetics, Intravenous
0
Guaifenesin
495W7451VQ
Butorphanol
QV897JC36D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-56Informations de copyright
Copyright © 2022 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. All rights reserved.